Leina Lunasco

Ms. Leina Lunasco

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Ophthalmology
Verified
Journal Article
Closed access
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
AJAlice C. Jiang
Alice C. Jiang
JBJoseph D. Boss
Joseph D. Boss
MHMing Hu
Ming Hu
NFNatalia Figueiredo
Natalia Figueiredo
SSSunil K. Srivastava
Sunil K. Srivastava

26 February 2021 in Ophthalmology Retina
Verified
Journal Article
Open access
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
RZRobert Zahid
Robert Zahid
PKPeter K. Kaiser
Peter K. Kaiser
JHJeffrey S. Heier
Jeffrey S. Heier
DBDavid M. Brown
David M. Brown
SSSunil K. Srivastava
Sunil K. Srivastava
To assess longitudinally the effect of anti-vascular endothelial growth factor (VEGF) treatment on ellipsoid zone (EZ) integrity, subretinal hyperreflective material (SHRM), and the sub-retinal pigment epithelium (sub-RPE) compartment in eyes with neovascular age-related macular degeneration (nAMD). Post hoc analysis of the OSPREY clinical trial, a prospective, double-masked, phase 2 study comparing brolucizumab 6 mg with aflibercept 2 mg over 56 weeks. Participants with treatment-naïve nAMD at the initiation of the trial were included in the analysis. Eyes were evaluated with spectral-domain OCT at 4-week intervals in the OSPREY trial (n = 81). Spectral-domain OCT scans collected from each visit were segmented automatically using a proprietary, machine learning-enabled higher-order feature-extraction platform for retinal layer, SHRM, and sub-RPE boundary lines, which were evaluated and corrected as needed by masked trained graders. The current analysis focused only on patients evaluated with the Cirrus (Zeiss) platform (n = 28). Outcome measures included change from baseline in EZ-RPE (i.e., photoreceptor outer segment) volume, EZ-RPE central subfield thickness (CST), total EZ attenuation, SHRM volume, SHRM CST, and total sub-RPE volume. The correlation between each of these measures and best-corrected visual acuity (BCVA) at each visit was evaluated. EZ-RPE volume and EZ-RPE CST showed significant increases, and total EZ attenuation, SHRM volume, SHRM CST, and total sub-RPE volume showed significant decreases from baseline at each visit from weeks 4 through 56 (P < 0.05 at each visit). Ellipsoid zone integrity measures and SHRM volume correlated significantly with BCVA at most visits (P < 0.05). No significant correlation was found between total sub-RPE volume and BCVA. EZ integrity, SHRM, and sub-RPE disease features in eyes with nAMD showed improvement as early as week 4 of anti-VEGF treatment. EZ integrity measures and SHRM volume were predictors of visual acuity over the first year of treatment.

5 September 2020 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
JAJoseph R. Abraham
Joseph R. Abraham
CWCharles Wykoff
Charles Wykoff
SASruthi Arepalli
Sruthi Arepalli
LLLeina Lunasco
Leina Lunasco
HYHannah J. Yu
Hannah J. Yu
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers

24 December 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Gagan KalraGagan Kalra
Gagan Kalra
HCHasan Cetin
Hasan Cetin
JWJon Whitney
Jon Whitney
SYSari Yordi
Sari Yordi
YCYavuz Cakir
Yavuz Cakir
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
The current study describes the development and assessment of innovative, machine learning (ML)-based approaches for automated detection and pixel-accurate measurements of regions with geographic atrophy (GA) in late-stage age-related macular degeneration (AMD) using optical coherence tomography systems. 900 OCT volumes, 100266 B-scans, and en face OCT images from 341 non-exudative AMD patients with or without GA were included in this study from both Cirrus (Zeiss) and Spectralis (Heidelberg) OCT systems. B-scan and en face level ground truth GA masks were created on OCT B-scan where the segmented ellipsoid zone (EZ) line, retinal pigment epithelium (RPE) line, and bruchs membrane (BM) line overlapped. Two deep learning-based approaches, B-scan level and en face level, were trained. The OCT B-scan model had detection accuracy of 91% and GA area measurement accuracy of 94%. The en face OCT model had detection accuracy of 82% and GA area measurement accuracy of 96% with primary target of hypertransmission on en face OCT. Accuracy was good for both devices tested (92–97%). Automated lesion size stratification for CAM cRORA definition of 250um minimum lesion size was feasible. High-performance models for automatic detection and segmentation of GA area were achieved using OCT systems and deep learning. The automatic measurements showed high correlation with the ground truth. The en face model excelled at identification of hypertransmission defects. The models performance generalized well across device types tested. Future development will include integration of both models to enhance feature detection across GA lesions as well as isolating hypertransmission defects without GA for pre-GA biomarker extraction.

23 February 2024 in Ophthalmology Retina
Verified
Journal Article
Open access
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
LLLeina Lunasco
Leina Lunasco
SYSari Yordi
Sari Yordi
HCHasan Cetin
Hasan Cetin
TLThuy K. Le
Thuy K. Le
SSSunil K. Srivastava
Sunil K. Srivastava

7 June 2021 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
JAJoseph R Abraham
Joseph R Abraham
CWCharles C Wykoff
Charles C Wykoff
SASruthi Arepalli
Sruthi Arepalli
LLLeina Lunasco
Leina Lunasco
HYHannah J Yu
Hannah J Yu
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
Background This study investigates the association of intraocular cytokine expression and ultrawide-field fluorescein angiography (UWFA) quantitative imaging biomarkers and their association with angiographical feature response after antivascular endothelial growth factor (VEGF) therapy in diabetic macular oedema (DME). Methods The IMAGINE DME study is a post hoc imaging biomarker and intraocular cytokine assessment from the DAVE study, a prospective DME clinical trial that included aqueous humour sampling and UWFA imaging. Fifty-four cytokines associated with inflammation and angiogenesis were evaluated through multiplex arrays. UWFA parameters were assessed using an automated feature analysis platform to determine ischaemic and leakage indices and microaneurysm (MA) count. Eyes were classified into UWFA responder or non-responder groups based on longitudinal quantitative UWFA parameter improvement. Cytokine expression was correlated with UWFA metrics and evaluated in the context of therapeutic response. Results Twenty-one eyes were included with a mean age of 55±10 years. Increased panretinal leakage index correlated with VEGF (r=0.70, p=0.0005), angiopoietin-like 4 (r=0.77, p=4.6E-5) and interleukin (IL)-6 (r=0.64, p=0.002). Panretinal ischaemic index was associated with tissue inhibitor of metalloproteinases 1 (TIMP-1, r=0.49, p=0.03) and peripheral ischaemia correlated with VEGF (r=0.45, p=0.05). MA count correlated with increased monocyte chemotactic protein-4 (MCP-4, r=0.60, p=0.004) and platelet and endothelial cell adhesion molecule 1 (PECAM-1, r=0.58, p=0.005). Longitudinal MA reduction was associated with decreased baseline VEGF and urokinase receptor (uPAR) (p<0.05). High baseline VEGF and IL-6 were associated with dramatic reduction in macular leakage (p<0.05). Conclusions Baseline and longitudinal quantitative UWFA imaging parameters correlated with multiple aqueous humour cytokine concentrations, including VEGF and IL-6. Further research is needed to assess the possible implications of using these findings for evaluating treatment response.